Diadema Partners LP Iovance Biotherapeutics, Inc. Transaction History
Diadema Partners LP
- $233 Billion
- Q4 2024
A detailed history of Diadema Partners LP transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Diadema Partners LP holds 100,000 shares of IOVA stock, worth $578,000. This represents 0.32% of its overall portfolio holdings.
Number of Shares
100,000Holding current value
$578,000% of portfolio
0.32%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding IOVA
# of Institutions
340Shares Held
247MCall Options Held
2.51MPut Options Held
3.5M-
Vanguard Group Inc Valley Forge, PA27.5MShares$159 Million0.0% of portfolio
-
Mhr Fund Management LLC New York, NY24.4MShares$141 Million24.02% of portfolio
-
Perceptive Advisors LLC New York, NY22.1MShares$128 Million5.46% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$123 Million0.0% of portfolio
-
State Street Corp Boston, MA12.2MShares$70.8 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $912M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...